美国Streck 213372 2 x 3.0 mL CD-Chex Plus BC CD4 Low 北京美科美生物长期供应,每个月都可以订购近期生产的批次。7-10天到货。快速报关。 咨询请电话/微信:13911177784,梅先生
2 x 3.0 mL CD-Chex Plus BC
213374
Streck
5 x 3.0 mL CD-Chex Plus BC
213378
Streck
2 x 3.0 mL CD-Chex Plus BC CD4 Low
213372
Streck
4 x 3.0 mL CD-Chex Plus BC CD4 Low, Normal
213375
Streck
10 x 3.0 mL CD-Chex Plus BC CD4 Low, Normal
213376
Streck
CD-Chex Plus BC is a positive procedural control for immunophenotyping by flow cytometry on Beckman Coulter flow cytometry systems. It is assayed for 30 parameters including T-lymphocytes, B-lymphocytes, granulocytes, monocytes, NK cells and a normal level of CD34+ cells. The whole blood control is available in two clinically relevant levels of CD4+ cells.
Product Description
CD-Chex Plus BC is a positive procedural control for monitoring immunophenotyping by flow cytometry on Beckman Coulter flow cytometry instruments. It provides 30 assayed CD parameters on a single control, including T-lymphocytes, B-lymphocytes, granulocytes, monocytes, and NK cells. It is available in two clinically relevant levels of CD4+ cells and is assayed for a normal level of CD34+ cells. Designed to mimic a patient sample, CD-Chex Plus BC is manufactured from normal human peripheral blood leukocytes and erythrocytes. The whole blood control offers 30-day open-vial stability. CD-Chex Plus BC features cap pierceable plastic vials for use with automated flow cytometry sample preparation instruments, reducing errors and improving laboratory workflow.
It is a positive procedural control designed to verify the accuracy and reproducibility of the steps involved in the process of the immunophenotyping including reagent staining, erythrocyte lysis, sample preparation, and instrument performance. CD-Chex Plus BC is designed for use on Beckman Coulter flow cytometry systems.
Features
Assayed for 30 parameters
Available in two clinically relevant levels of CD4+ cells
Assayed for a normal level of CD34+ cells
Designed for use on Beckman Coulter flow cytometry systems
30-day open-vial stability
90-day closed-vial stability
Benefits
Helps laboratory meet CLIA guidelines
Established assay ranges provide less room for error
Reduces the need for labs to hold and validate patient samples for use as a control